Unoccupied αvβ3 integrin regulates osteoclast apoptosis by transmitting a positive death signal

Molecular Endocrinology

Volumn 19, Issue 3, 2005, Pages 771-780

  Zhao, Haibo ^a   Ross, F Patrick ^a   Teitelbaum, Steven L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CASPASE 8; CASPASE 9; COLLAGEN; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MATRIX PROTEIN; VITRONECTIN; VITRONECTIN RECEPTOR;

ADOLESCENT; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC TRANSDUCTION; MOUSE; MUTATION; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BONE MARROW CELLS; CASPASE 8; CASPASES; CELL SURVIVAL; CELLS, CULTURED; DNA, COMPLEMENTARY; FLOW CYTOMETRY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; IMMUNOPRECIPITATION; INTEGRIN ALPHAVBETA3; INTEGRINS; LENTIVIRUS; MACROPHAGES; MICE; MICE, TRANSGENIC; MUTATION; OSTEOBLASTS; OSTEOCLASTS; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TIME FACTORS; VITRONECTIN;

LENTIVIRUS;

EID: 14844317695     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0161     Document Type: Article

References (50)

1. Giancotti FG, Ruoslahti E 1999 Integrin signaling. Science 285:1028-1033
2. Schwartz MA, Ginsberg MH 2002 Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 4:E65-E68
3. Teitelbaum SL 2000 Osteoclasts, integrins and osteoporosis. J Bone Miner Metab 18:344-349
4. Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton M 1989 The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 109:1817-1826
5. Inoue M, Namba N, Chappel J, Teitelbaum SL, Ross FP 1998 Granulocyte-macrophage colony stimulating factor reciprocally regulates αv-associated integrins on murine osteoclast precursors. Mol Endocrinol 12:1955-1962
6. Chambers TJ, Fuller K, Darby JA, Pringle JAS, Horton MA 1986 Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Miner 1:127-135
7. Engleman VW, Nickols GA, Ross FP, Horton MA, Settle SL, Ruminski PG, Teitelbaum SL 1997 A peptidomimetic antagonist of the αvβ3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest 99:2284-2292
8. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL 2000 Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105:433-440
9. Feng X, Novack DV, Faccio R, Dry DS, Aya K, Boyer MI, McHugh KP, Ross FP, Teitelbaum SL 2001 A Glanzmann's mutation of the β3 integrin gene specifically impairs osteoclast function. J Clin Invest 107:1137-1144
10. Faccio R, Zallone A, Ross FP, Teitelbaum SL 2003 c-Fms and the αvβ3 integrin collaborate during osteoclast differentiation. J Clin Invest 111:749-758
11. Frisch SM, Screaton RA 2001 Anoikis mechanisms. Curr Opin Cell Biol 13:555-562
12. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA 2001 Apoptosis of adherent cells by recruitment of caspase-8 to uniigated integrins. J Cell Biol 155:459-470
13. Takeshita S, Kaji K, Kudo A 2000 Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 15:1477-1488
14. Fesik SW 2000 Insights into programmed cell death through structural biology. Cell 103:273-282
15. Kaufmann SH, Hengartner MO 2001 Programmed cell death: alive and well in the new millennium. Trends Cell Biol 11:526-534
16. Hengartner MO 2000 The biochemistry of apoptosis. Nature 407:770-776
17. Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, Zhou Q, Ellerby HM, Ellerby LM, Bredesen D, Green DR, Reed JC, Froelich CJ, Salvesen GS 1998 Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 273:27084-27090
18. Kreuz S, Siegmund D, Rumpf J-J, Samel D, Leverkus M, Janssen O, Hacker G, Dittrich-Breiholz O, Kracht M, Scheurich P, Wajant H 2004 NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J Cell Biol 166:369-380
19. Suda T, Takahashi N, Martin TJ 1992 Modulation of osteoclast differentiation. Endocr Rev 13:66-80
20. Manolagas SC 2000 Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21: 115-137
21. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF 1996 Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 2:1132-1136
22. Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa, M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M 1997 Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186:489-495
23. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF 1995 Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487
24. Selander K, Monkkonen J, Karhukorpi E, Harkonen P, Hannuniemi R, Vaananen H 1996 Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol Pharmacol 50:1127-1138
25. Horton MA 1997 The αvβ3 integrin "vitronectin receptor." Int J Biochem Cell Biol 29:721-725
26. Sato M, Sardana MK, Grasser WA, Garsky VM, Murray JM, Gould RJ 1990 Echistatin is a potent inhibitor of bone resorption in culture. J Cell Biol 111:1713-1723
27. King KL, D'Anza JJ, Bodary S, Pitti R, Siegel M, Lazarus RA, Dennis MS, Hammonds Jr RG, Kukreja SC 1994 Effects of kistrin on bone resorption in vitro and serum calcium in vivo. J Bone Miner Res 9:381-387
28. Sakai H, Kobayashi Y, Sakai E, Shibata M, Kato Y 2000 Cell adhesion is a prerequisite for osteoclast survival. Biochem Biophys Res Commun 270:550-556
29. Brooks PC, Clark RA, Cheresh DA 1994 Requirement of vascular integrin αvβ3 for angiogenesis. Science 264: 569-571
30. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA 1994 Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164
31. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Cullere M, Ross FP, Coller BS, Teitelbaum S, Hynes RO 1999 β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 103: 229-238
32. Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM 2002 Enhanced pathological angiogenesis in mice lacking 3 integrin or 3 and 5 integrins. Nat Med 8:27-34
33. Stupack DG, Cheresh DA 2002 Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 115: 3729-3738
34. Brassard DL, Maxwell E, Malkowski M, Nagabhushan TL, Kumar CC, Armstrong L 1999 Integrin αvβ3-mediated activation of apoptosis. Exp Cell Res 251:33-45
35. Kumar S, Lavin MF 1996 The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ 3:255-267
36. Okahashi N, Koide M, Jimi E, Suda T, Nishihara T 1998 Caspases (interleukin-1-β-converting enzyme family proteases) are involved in the regulation of the survival of osteoclasts. Bone 23:33-41
37. Benford HL, McGowan NWA, Helfrich MH, Nuttall ME, Rogers MJ 2001 Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 28:465-473
38. Boatright KM, Salvesen GS 2003 Mechanisms of caspase activation. Curr Opin Cell Biol 15:725-731
39. Akiyama T, Bouillet P, Miyazaki T, Kadono Y, Chikuda H, Chung U-I, Fukuda A, Hikita A, Seto H, Okada T, Inaba T, Sanjay A, Baron R, Kawaguchi H, Oda H, Nakamura K, Strasser A, Tanaka S 2003 Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J 22:6653-6664
40. Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM 2003 Osteoclast apoptosis: the role of fas in vivo and in vitro. Endocrinology 144:5545-5555
41. Gingery A, Bradley E, Shaw A, Oursler MJ 2003 Phosphatidylinositol 3-kinase coordinately activates the MEK/ ERK and AKT/NFκB pathways to maintain osteoclast survival. J Cell Biochem 89:165-179
42. Lakkakorpi PT, Horton MA, Helfrich MH, Karhukorpi E-K, Vaananen HK 1991 Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J Cell Biol 115:1179-1186
43. Mulari MT, Zhao H, Lakkakorpi PT, Vaananen HK 2003 Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake. Traffic 4:113-125
44. Arnoult D, Parone P, Martinou J-C, Antonsson B, Estaquier J, Ameisen JC 2002 Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J Cell Biol 159:923-929
45. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L 1998 A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463-8471
46. Shikama Y, Shen L, Yonetani M, Miyauchi J, Miyashita T, Yamada M 2002 Death effector domain-only polypeptides of caspase-8 and -10 specifically inhibit death receptor-induced cell death. Biochem Biophys Res Commun 291:484-493
47. Kim H, Lee J, Soung Y, Park W, Kim S, Lee J, Park J, Cho Y, Kim C, Jeong S, Nam S, Kim S, Lee J, Yoo N, Lee S 2003 Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 125:708-715
48. Onishi M, Nosaka T, Misawa K, Mui AL-F, Gorman D, McMahon M, Miyajima A, Kitamura T 1998 Identification and characterization of a constitutive active STAT5 mutant that promotes cell proliferation. Mol Cell Biol 18: 3871-3879
49. Feng X, Takeshita S, Namba N, Wei S, Teitelbaum SL, Ross FP 2002 Tyrosines 559 and 807 in the cytoplasmic tail of the m-csf receptor play distinct roles in osteoclast differentiation and function. Endocrinology 143:4868-4874
50. Morita S, Kojima T, Kitamura T 2000 Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7:1063-1066